Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-099211
Filing Date
2023-04-12
Accepted
2023-04-12 16:10:57
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A d425141ddefa14a.htm DEFA14A 29641
2 GRAPHIC g425141snap2.jpg GRAPHIC 1272
3 GRAPHIC g425141snap3.jpg GRAPHIC 1241
4 GRAPHIC g425141snap4.jpg GRAPHIC 892
5 GRAPHIC g425141snap6.jpg GRAPHIC 945
6 GRAPHIC g425141snap7.jpg GRAPHIC 1261
7 GRAPHIC g425141sp1.jpg GRAPHIC 4129
  Complete submission text file 0001193125-23-099211.txt   44903
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39659 | Film No.: 23815813
SIC: 8071 Services-Medical Laboratories